Open AccessDrugs affecting hemostasis function
Author(s) -
В. А. Макаров
Publication year - 1988
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj99554
Subject(s) - hemostasis , fibrinolysis , fibrin , blood clotting , pharmacology , chemistry , coagulation , medicine , immunology , biomedical engineering
At present there are a large number of drugs that can affect various parts of hemostasis. By the nature of the effect on the process of fibrin formation drugs are divided into Procoagulants (accelerating this process) and anticoagulants (inhibiting the formation of fibrin). Fibrinolysis activators and inhibitors are known and used in the clinic. A number of drugs affect cellular hemostasis, primarily on the adhesive-aggregative ability of blood forming elements. The action of many compounds on plasma and cellular hemostasis is mediated by their effect on. the vascular wall with subsequent release of regulators of blood clotting, fibrinolysis and aggregation of formular elements.